The Supraoptic Nucleus (SON) is a bilateral hypothalamic nucleus located adjacent to the optic chiasm that contains magnocellular neurosecretory neurons producing vasopressin (also known as antidiuretic hormone, ADH). These neurons are essential for water homeostasis, cardiovascular regulation, and stress responses[1].
In neurodegenerative diseases, dysfunction of vasopressin neurons contributes to autonomic disturbances, sleep-wake cycle disruptions, and neuroendocrine imbalances that affect disease progression and quality of life[2].
| Property | Value |
|---|---|
| Category | Hypothalamic Neurosecretory |
| Location | Supraoptic nucleus, hypothalamus (adjacent to optic chiasm) |
| Cell Types | Magnocellular neurosecretory neurons |
| Primary Neurotransmitter | Vasopressin (peptide), Glutamate |
| Key Markers | AVP, Copeptin, Neurophysin I |
The supraoptic nucleus is situated:
The SON contains approximately 20,000-30,000 magnocellular neurons in humans, characterized by:
Afferent (Input) Pathways:
Efferent (Output) Pathways:
Vasopressin neurons regulate water balance through:
Osmoregulation:
Volume Regulation:
Vasopressin affects cardiovascular function through:
Vascular Effects (V1 receptors):
Cardiac Effects:
Stress Response:
Social Behavior:
Vasopressin neurons are affected in AD through:
In PD, vasopressin dysfunction contributes to:
MSA severely affects vasopressin neurons:
Vasopressin abnormalities in HD include:
Assessment of vasopressin neuron function:
Pharmacological:
Non-pharmacological:
Current research areas include:
The study of Supraoptic Nucleus Vasopressin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brown CH, Bains JS, Ludwig M, Tasker JG. Physiological regulation of magnocellular neurosecretory neurons. J Neuroendocrinol. 2020;32(7):e12860. 2020. ↩︎
[Raggenbass M. Overview of vasopressin functions. Prog Brain Res. 2008;170:51-57](https://doi.org/10.1016/S0079-6123(08). 2008. ↩︎
Sofroniew MV, Weindl A. Projection from the parvocellular vasopressin-containing neurons of the suprachiasmatic nucleus to external regions of the median eminence. J Comp Neurol. 1980;193(3):659-675. 1980. ↩︎
Richard D, Bourque CW. Synaptic control of rat supraoptic neurons. J Physiol. 1995;489(Pt 2):567-577. 1995. ↩︎
Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci. 2008;9(7):519-531. 2008. ↩︎
Koshimizu TA, Nakamura K, Egashira N, et al. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 2012;92(4):1813-1864. 2012. ↩︎
Donaldson ZR, Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science. 2008;322(5903):900-904. 2008. ↩︎
Jellinger KA. Neuropathology of autonomic failure in Parkinson's disease. J Neural Transm Suppl. 1997;50:87-96. 1997. ↩︎
Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12(2):133-147. 1997. ↩︎
Ball SG, Khopkar S, Quinn N. Vaptans and the treatment of hyponatraemia in neurological disorders. Nat Rev Neurol. 2013;9(8):451-462. 2013. ↩︎